Patel P et al. |
Structural requirements for activation of the 5-oxo-6E,8Z, 11Z,14Z-eicosatetraenoic acid (5-oxo-ETE) receptor: identification of a mead acid metabolite with potent agonist activity. |
2008 |
J. Pharmacol. Exp. Ther. |
pmid:18292294
|
Cleland LG et al. |
Dietary (n-9) eicosatrienoic acid from a cultured fungus inhibits leukotriene B4 synthesis in rats and the effect is modified by dietary linoleic acid. |
1996 |
J. Nutr. |
pmid:8648425
|
Chu SH and Hegsted DM |
Assessment of the essential fatty acid requirement in gerbils by polyunsaturated fatty acid ratio. |
1981 |
J. Nutr. |
pmid:6792330
|
Nguyen TT et al. |
New model of a scaling dermatosis: induction of hyperproliferation in hairless mice with eicosa-5,8,11-trienoic acid. |
1981 |
J. Invest. Dermatol. |
pmid:7229430
|
James MJ et al. |
Effect of dietary supplementation with n-9 eicosatrienoic acid on leukotriene B4 synthesis in rats: a novel approach to inhibition of eicosanoid synthesis. |
1993 |
J. Exp. Med. |
pmid:8245797
|
Neufeld EJ et al. |
High affinity esterification of eicosanoid precursor fatty acids by platelets. |
1983 |
J. Clin. Invest. |
pmid:6308046
|
Oliw EH et al. |
Oxygenation of 5,8,11-eicosatrienoic acid by prostaglandin H synthase-2 of ovine placental cotyledons: isolation of 13-hydroxy-5,8,11-eicosatrienoic and 11-hydroxy-5,8,12-eicosatrienoic acids. |
1997 |
J. Chromatogr. B Biomed. Sci. Appl. |
pmid:9106061
|
FULCO AJ and MEAD JF |
Metabolism of essential fatty acids. VIII. Origin of 5,8,11-eicosatrienoic acid in the fat-deficient rat. |
1959 |
J. Biol. Chem. |
pmid:13654388
|
MEAD JF and SLATON WH |
Metabolism of essential fatty acids. III. Isolation of 5,8,11-eicosatrienoic acid from fat-deficient rats. |
1956 |
J. Biol. Chem. |
pmid:13319291
|
Stenson WF et al. |
Leukotriene B formation by neutrophils from essential fatty acid-deficient rats. |
1984 |
J. Biol. Chem. |
pmid:6090446
|
Elliott WJ et al. |
Calcium-dependent oxidation of 5,8,11-icosatrienoic acid by the cyclooxygenase enzyme system. |
1986 |
J. Biol. Chem. |
pmid:3084488
|
Hammarström S |
Conversion of 5,8,11-eicosatrienoic acid to leukotrienes C3 and D3. |
1981 |
J. Biol. Chem. |
pmid:6780563
|
Jakschik BA et al. |
Products derived from 5,8,11-eicosatrienoic acid by the 5-lipoxygenase-leukotriene pathway. |
1983 |
J. Biol. Chem. |
pmid:6313677
|
Lagarde M et al. |
Prostaglandin E2-like activity of 20:3n-9 platelet lipoxygenase end-product. |
1985 |
FEBS Lett. |
pmid:3918886
|
Adkisson HD et al. |
Unique fatty acid composition of normal cartilage: discovery of high levels of n-9 eicosatrienoic acid and low levels of n-6 polyunsaturated fatty acids. |
1991 |
FASEB J. |
pmid:2001795
|
Orning L et al. |
Formation of leukotrienes E3, E4 and E5 in rat basophilic leukemia cells. |
1981 |
Eur. J. Biochem. |
pmid:6273168
|
Kuroki F et al. |
Serum n3 polyunsaturated fatty acids are depleted in Crohn's disease. |
1997 |
Dig. Dis. Sci. |
pmid:9201073
|
Coste TC et al. |
Influence of pancreatic status and sex on polyunsaturated fatty acid profiles in cystic fibrosis. |
2008 |
Clin. Chem. |
pmid:18089657
|
Kroegel C et al. |
Inhibition of the eosinophil chemotactic factor (ECF) release from human PMNs and rat mast cells by arachidonic acid analogs. |
1981 |
Cell. Immunol. |
pmid:7237570
|
Kühn H et al. |
The inactivation of lipoxygenases by acetylenic fatty acids. |
1984 |
Biomed. Biochim. Acta |
pmid:6440550
|